Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Bullboard Posts
Post by Trademark11on Aug 11, 2018 6:47am
365 Views
Post# 28444165

Guidance

GuidanceTake a listen to the webcast at https://fool.wistia.com/medias/ytdemrm5x5 (which was aired June 15/18)  between 21:30 to 22 minutes of the discussion... Todd Zehnder reiterates Q2 guidance of 8-9% over Q1 with similar margins (of 27% FCF).  That corroborates analysis of revenues of between $15.2 mil - 15.4  revenue with FFO of $4.1 mil-  $4.15 mil.    Original guidance by management at the Q1 conference call was for revenue between 14.8 and 15.3. mil.  This updated (indirect) guidance is at the high end of revenue.

Note June 15/18 is 10 production days of the end of the quarter.   This statement by the COO so late in the quarter could be seen as highly predictable confirmation that the company has again acheived phenomenal growth yet again ... Tuesday may be a great day for shareholders if this holds true.
Bullboard Posts